(3.138.134.229)
Users online: 20433     
Ijournet
Email id
 

Indian Journal of Public Health Research & Development
Year : 2018, Volume : 9, Issue : 1
First page : ( 321) Last page : ( 326)
Print ISSN : 0976-0245. Online ISSN : 0976-5506.
Article DOI : 10.5958/0976-5506.2018.00059.1

Relationships of B-RAF Immuno-expression with Clinic Pathological Features in Patients with Colorectal Carcinoma in Wahidin sudirohusodo Hospital Makassar

 Warsinggih1, Winata Nengah1

1Department of Surgery Medical Faculty of Hasanuddin University, Makassar

Online published on 7 February, 2018.

Abstract

Background

Colorectal Cancer is a malignancy that is due in addition to environmental factors, as well as genetic mutations. Oncogene mutation of B-RAF V600E plays an important role in the cascade of intracellular signaling pathways barriers mitogen-activated kinase protein in colorectal cancer. B-RAF mutations in colorectal cancer ranges from 5–20%. The purpose of this study was to determine immune-expression B-RAF V600E against clinic pathologic overview of colorectal cancer.

Materials and Method

This research is an analytic cross-sectional study on 40 cases of colorectal carcinoma cases. Immune-hystochemical staining of the B-RAF V600E thin piece of the tumor mass to evaluate their immune-expression B-RAF V600E and Chi-square test. Data were analyzed with SPSS 15.0 For Windows to determine the relationship immune-expression B-RAF with clinic pathologic. Then the data were tested using Spearman's statistical test.

Results

Significance is determined by the value of P <0.05. Of the 40 patients with carcinoma colorectal the staining immune-expression B-RAF V600E association remained immune-expression B-RAF V600E against gender (p = 0.041), tumor location (p = 0.020), TNM staging (p = 0.011) and the degree of differentiation (p = 0.023) but no significant relationship between immune-expression B-RAF and histopathological picture (p = 0.090).

Conclusion

Immune-expression B-RAF significantly associated with clinic pathologic features of colorectal carcinoma and these data show immune-expression B-RAF V600E can be used as a standard clinical and pathological for better treatment against colorectal carcinoma.

Top

Keywords

Colorectal carcinoma, B-RAF, B-RAF V600E, immune-expression B-RAF, clinic pathologic, mutation, oncogen mutation, environmental factors.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
760,592,267 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.